Deciphera Pharmaceuticals, Inc.

VANGUARD GROUP INC

Report date

3/31/2024

Quarter

2024 Q1

Filed

5/10/2024

Shares

4,565,044

Value ($000)

71,808

Weight

0.0%

2019 Q4 - 2024 Q1 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q1	5/10/2024	71,808	0.0%	4,565,044	3/31/2024
2023 Q4	3/11/2024	70,998	0.0%	4,401,636	12/31/2023
2023 Q3	12/18/2023	55,566	0.0%	4,368,433	9/30/2023
2023 Q2	8/14/2023	61,843	0.0%	4,392,270	6/30/2023
2023 Q1	7/14/2023	71,241	0.0%	4,611,090	3/31/2023
2022 Q4	2/10/2023	77,776	0.0%	4,745,321	12/31/2022
2022 Q3	11/14/2022	88,708	0.0%	4,794,993	9/30/2022
2022 Q2	8/12/2022	57,768	0.0%	4,392,946	6/30/2022
2022 Q1	5/13/2022	33,321	0.0%	3,594,512	3/31/2022
2021 Q4	2/14/2022	33,895	0.0%	3,469,317	12/31/2021
2021 Q3	11/12/2021	133,758	0.0%	3,936,385	9/30/2021
2021 Q2	8/13/2021	143,794	0.0%	3,927,704	6/30/2021
2021 Q1	5/14/2021	177,032	0.0%	3,948,062	3/31/2021
2020 Q4	2/12/2021	218,907	0.0%	3,835,758	12/31/2020
2020 Q3	11/16/2020	193,620	0.0%	3,774,261	9/30/2020
2020 Q2	8/14/2020	211,980	0.0%	3,549,561	6/30/2020
2020 Q1	5/15/2020	103,541	0.0%	2,514,972	3/31/2020
2019 Q4	2/14/2020	136,975	0.0%	2,200,761	12/31/2019